215 First Street, 3rd Floor
About Relay Therapeutics
Relay Therapeutics was founded on the premise that putting protein motion at the heart of drug discovery can dramatically expand therapeutic possibilities.
CSO and Co-Founder: Mark Murcko, Ph.D.
CEO: Sanjiv Patel
VP, Corporate Development and Strategy: Deborah Palestrant
12 articles with Relay Therapeutics
Relay Therapeutics announced the appointment of Steven Kafka, Ph.D., to its board of directors.
Andrew Huberman, researcher in the Stanford University Department of Neurobiology, is taking an unusual approach to investigating possible treatments for glaucoma and anxiety disorders—virtual reality.
Advances in data storage and processing, as well as biomarker identification, has led to cutting-edge breakthroughs in clinical and research imaging technology. Here’s a look at just a few of these stories.
Relay Therapeutics, a biotech company dedicated to developing breakthrough medicines by leveraging insights from protein motion, today announced the appointments of Don Bergstrom, M.D., Ph.D. as Executive Vice President, Head of Research and Development, Brian Adams as General Counsel, and Tom Catinazzo as Vice President of Finance.
Relay Therapeutics, a biotech company dedicated to developing breakthrough medicines by leveraging insights from protein motion, today announced that Sanjiv Patel, M.D., President and Chief Executive Officer, will present at Cowen and Company’s 38th Annual Health Care Conference.
Based in Cambridge, MA and founded in February 2016, Relay Therapeutics focuses on developing therapeutics based on protein motion.
BioSpace is proud to present its NextGen "Class of 2018," a list of 20 up-and-coming life science companies in North America that started up no earlier than 2015.
The round was led by BVF Partners, with new investors GV, Casdin Capital, EcoR1 Capital and Section 32.
O’Brien joins Relay Therapeutics with significant strategic human resources experience in the life sciences industry.
Relay Therapeutics Names Deborah Palestrant, Ph.D., Vice President Of Corporate Development And Strategy